L'hypertension artérielle pulmonaire primitive: une complication rare mais souvent mortelle du Crest syndrome

Stupi, 1986, Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis, Arthritis Rheum, 29, 515, 10.1002/art.1780290409 Salerni, 1977, Pulmonary hyper-tension in the CREST syndrome variant of progressive systemic sclerosis, Ann Intern Med, 86, 394, 10.7326/0003-4819-86-4-394 Chérin, 1991, Hypertension artérielle pulmonaire et maladies systémiques, Rev Rhum, 58, 387 D'Angelo, 1969, Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight marched controls, Am J Med, 46, 428, 10.1016/0002-9343(69)90044-8 Ungerer, 1983, Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis, Am J Med, 75, 65, 10.1016/0002-9343(83)91169-5 Stone, 1995, Carbon monoxide diffusing capacity (DLCO) correlates poorly with pulmonary artery pressures in limited scleroderma, Arthritis. Rheum, 38, S334 Christman, 1992, An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension, N Engl J Med, 327, 70, 10.1056/NEJM199207093270202 Loscalzo, 1992, Endothelial dysfunction in pulmonary hypertension [Editorial], N Engl J Med, 327, 17, 10.1056/NEJM199207093270209 Cacoub, 1996, Plasma levels of thrombomoduline in pulmonary hypertension, Am J Med, 100, 160, 10.1016/S0002-9343(96)80070-2 Kahalet, 1982, Elevated levels of circulating platelet aggregates and betathromboglobulin in scleroderma, Ann Intern Med, 96, 610, 10.7326/0003-4819-96-5-610 Rich, 1986, Antinuclear antibodies in primary pulmonary hypertension, J Am Coll Cardiol, 8, 1307, 10.1016/S0735-1097(86)80301-1 Scully, 1992, Case records of the Massachusetts General Hospital, N Engl J Med, 328, 1682 Rich, 1992, The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension, N Engl J Med, 327, 76, 10.1056/NEJM199207093270203 Philippoteau, 1990, Étude des drogues vasodilatatrices dans l'hypertension artérielle pulmonaire des sclérodermies systémiques, Rev Mal Respir, 7, 249 Rubin, 1990, Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol) . Results of a randomized trial, Ann Intern Med, 112, 485, 10.7326/0003-4819-112-7-485 De La Mata, 1994, Long-term Iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases, Arthritis Rheum, 37, 1528, 10.1002/art.1780371018 Barst, 1996, A comparizon of continuous intra-venous epoprostenol (prostacyclin) with conventionnal therapy for primary pulmonary hypertension, N Engl J Med, 1, 296, 10.1056/NEJM199602013340504 Pepke-Zaba, 1991, Inhaled nitric oxyd as a cause of selective pulmonary vasodilatation in pulmonary hypertension, Lancet, 338, 1173, 10.1016/0140-6736(91)92033-X